Johnson BH - Search Results

1

Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: signaling pathway interactions.

Garza AS, Miller AL, Johnson BH, Thompson EB. Garza AS, et al. Among authors: johnson bh. Leuk Res. 2009 May;33(5):717-27. doi: 10.1016/j.leukres.2008.10.006. Epub 2008 Nov 13. Leuk Res. 2009. PMID: 19012965 Free PMC article.

2

Glucocorticoids and polyamine inhibitors synergize to kill human leukemic CEM cells.

Miller AL, Johnson BH, Medh RD, Townsend CM, Thompson EB. Miller AL, et al. Among authors: johnson bh. Neoplasia. 2002 Jan-Feb;4(1):68-81. doi: 10.1038/sj.neo.7900208. Neoplasia. 2002. PMID: 11922393 Free PMC article.

3

Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.

Thompson EB, Johnson BH. Thompson EB, et al. Among authors: johnson bh. Recent Prog Horm Res. 2003;58:175-97. doi: 10.1210/rp.58.1.175. Recent Prog Horm Res. 2003. PMID: 12795419 Review.

4

Gene networks in glucocorticoid-evoked apoptosis of leukemic cells.

Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG, Thompson EB. Webb MS, et al. Among authors: johnson bh. J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):183-93. doi: 10.1016/s0960-0760(03)00194-8. J Steroid Biochem Mol Biol. 2003. PMID: 12943703

5

p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.

Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB. Miller AL, et al. Among authors: johnson bh. Mol Endocrinol. 2005 Jun;19(6):1569-83. doi: 10.1210/me.2004-0528. Epub 2005 Apr 7. Mol Endocrinol. 2005. PMID: 15817653

6

Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells.

Miller AL, Garza AS, Johnson BH, Thompson EB. Miller AL, et al. Among authors: johnson bh. Cancer Cell Int. 2007 Mar 28;7:3. doi: 10.1186/1475-2867-7-3. Cancer Cell Int. 2007. PMID: 17391526 Free PMC article.

7

Interactions of the phenylpyrazolo steroid cortivazol with glucocorticoid receptors in steroid-sensitive and -resistant human leukemic cells.

Thompson EB, Srivastava D, Johnson BH. Thompson EB, et al. Among authors: johnson bh. Cancer Res. 1989 Apr 15;49(8 Suppl):2253s-2258s. Cancer Res. 1989. PMID: 2702665

8

Transfected glucocorticoid receptor and certain GR fragments evoke cell death in malignant lymphoid, not myeloid cell lines.

Nazareth LV, Johnson BH, Chen H, Thompson EB. Nazareth LV, et al. Among authors: johnson bh. Leukemia. 1996 Nov;10(11):1789-95. Leukemia. 1996. PMID: 8892683

9

Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.

Medh RD, Saeed MF, Johnson BH, Thompson EB. Medh RD, et al. Among authors: johnson bh. Cancer Res. 1998 Aug 15;58(16):3684-93. Cancer Res. 1998. PMID: 9721879

10

Identification of genes leading to glucocorticoid-induced leukemic cell death.

Thompson EB, Webb MS, Miller AL, Fofanov Y, Johnson BH. Thompson EB, et al. Among authors: johnson bh. Lipids. 2004 Aug;39(8):821-5. doi: 10.1007/s11745-004-1302-7. Lipids. 2004. PMID: 15638253 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters